Related Experiment Video
Updated: May 1, 2026

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Increased risk of stroke among patients with ulcerative colitis: a population-based matched cohort study
Joseph J Keller1, Jui Wang, Ya-Li Huang
1School of Public Health, College of Public Health and Nutrition, Taipei Medical University, Taipei, Taiwan.
Insights
Patients with ulcerative colitis (UC) face a doubled risk of subsequent stroke, particularly those over 50. This finding highlights the importance of stroke risk assessment in UC patients.
Area of Science:
- Gastroenterology
- Neurology
- Epidemiology
Background:
- Inflammatory bowel disease (IBD), including ulcerative colitis (UC), is linked to increased risks of venous thromboembolism and atherosclerosis.
- The association between UC and stroke risk remains controversial in existing literature.
Purpose of the Study:
- To investigate the risk of subsequent stroke in patients diagnosed with ulcerative colitis (UC).
- To compare stroke risk in UC patients versus a matched cohort without IBD using population-based data.
Main Methods:
- Analysis of administrative claims data from Taiwan's National Health Insurance Database.
- Inclusion of 516 UC patients and 2,579 IBD-free comparison subjects.
- Utilized Cox proportional hazards regressions to assess stroke risk, with subgroup analyses by age and gender.
Main Results:
- Adjusted analyses revealed a 2.045-fold increased hazard ratio (HR) for subsequent stroke in UC patients compared to controls.
- Increased stroke risk was significant for UC patients over 50 years old.
- The association remained significant in both men (HR=2.153) and women (HR=2.750).
Conclusions:
- This cohort study identified a significantly elevated risk of subsequent stroke among Taiwanese UC patients.
- The findings underscore the need for vigilance regarding cerebrovascular events in the UC population.
Background:
The risk of venous thromboembolism (VTE) and the development of atherosclerosis are increased in patients with inflammatory bowel disease (IBD). Ulcerative colitis (UC) is one type of IBD; however, there is controversy in the literature regarding the association between UC and stroke. The present cohort study estimated the risk of subsequent stroke among UC patients compared with that among matched comparison subjects drawn from a population-based data set in Taiwan.
Methods:
This investigation analyzed administrative claims data sourced from the Taiwan National Health Insurance Database. Our study consisted of a study cohort comprising 516 UC patients and a comparison cohort of 2,579 subjects without IBD. Cox proportional hazards regressions were performed to estimate the risk of subsequent stroke during the follow-up period. We also conducted additional analyses investigating the risk of subsequent stroke by age group and gender.
Results:
After adjusting for selected medical co-morbidities and recent prescriptions of selected pharmaceuticals, the hazard ratio (HR) for subsequent stroke among patients with UC was 2.045 (95 % confidence interval (CI) = 1.374-3.043) than that among comparison subjects. While we did not detect an association between stroke and UC among patients aged 30-40 or 40-50 years, we did detect increased risks for stroke among UC patients aged over 50 years (HR = 2.045). We also found the association to remain significant for both men (HR = 2.153) and women (HR = 2.750).
Conclusions:
This study detected an increased HR for subsequent stroke among Taiwanese UC patients hen compared to that among matched comparison patients without IBD.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Ulcerative Colitis
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease IV: Clinical Manifestations
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Peptic Ulcer Disease II: Pathophysiology

